Header Logo

Connection

BILAL OMER to Leukemia, Myeloid, Acute

Back to Details
This is a "connection" page, showing publications BILAL OMER has written about Leukemia, Myeloid, Acute.
BILAL OMER
Connection Strength
0.435
Leukemia, Myeloid, Acute
  1. International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML. Blood Adv. 2025 Dec 09; 9(23):6047-6058.
    View in: PubMed
    Score: 0.159
  2. CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity. Blood. 2021 07 29; 138(4):318-330.
    View in: PubMed
    Score: 0.117
  3. Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1. Mol Ther. 2017 09 06; 25(9):2202-2213.
    View in: PubMed
    Score: 0.088
  4. Leukocyte arylsulphatase A activity in acute leukemia. Cancer Biochem Biophys. 1994 Apr; 14(1):53-6.
    View in: PubMed
    Score: 0.071
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.